GTC
HZNP

Ghost Tree Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Ghost Tree Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-129,100
Closed -$2.09M – 92
2016
Q4 		$2.09M Sell
129,100
-170,900
-57% -$3.1M 0.5% 54
2016
Q3 		$5.44M Buy
300,000
+100,000
+50% +$1.95M 0.88% 43
2016
Q2 		$3.29M Buy
+200,000
New +$3.24M 0.95% 39

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ghost Tree Capital's HZNP Position: Q4 2022 in Review

Ghost Tree Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 75,000 shares — an estimated $4.64M sold.

Ghost Tree Capital first reported a position in HZNP in Q4 2013 and held it in 12 quarters. The position peaked at $7.98M in Q2 2022. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Ghost Tree Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Ghost Tree Capital sold 75,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $4.64M.
  • Ghost Tree Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 12 quarters.
  • Ghost Tree Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.98M in Q2 2022.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Ghost Tree Capital's 13F filing for Q4 2022, filed 14 Feb 2023.